ACTEMRA®

(Tocilizumab)

Documentation

Patented
Approved 2010
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: ADCC Antagonist
Target: CD126(IL-6R)
Indication Category: Autoimmunity Cancer

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA